[PDF] Top 20 La innovación en los medios digitales locales
Has 10000 "La innovación en los medios digitales locales" found on our website. Below are the top 20 most common "La innovación en los medios digitales locales".
Abstract: Liver cirrhosis is a chronic disease that is characterized by the presence of fibrosis and
... of liver cirrhosis and its clinical history, since with treatment and/or withdrawal of the stimuli can slow the progression of the disease and maintain it in compensated stage for more time improving ... See full document
14
Article: Comparative histomorphological study of non affected and affected liver by fascioliasis in Black Bengal goat
... affected liver by fascioliasis in Black Bengal ...affected liver were ...affected liver of Black Bengal ...the liver in chronic fascioliasis characterized by increase in the size ... See full document
10
Idiopathic non-cirrhotic portal hypertension: a review
... rare disease characterized of intrahepatic portal hypertension in the absence of cirrhosis or other causes of liver disease and splanchnic venous ...s disease, etc.), 2) ... See full document
10
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response
... that chronic liver disease and HCC develop in the presence of these ...nonalcoholic liver diseases, it is expected that autophagy induction should also improve liver ... See full document
11
Non ∆F 508 Cystic Fibrosis Diagnosed at Age 50 in an African American Male: A Primary Care Perspective
... develop chronic infection of the respiratory tract with a characteristic array of bacterial flora [5, 7], leading to progressive respiratory insufficiency and eventual respiratory ...cystic fibrosis ... See full document
318
Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography
... methotrexate-associated liver injury is related to comorbid risk factors such as diabetes, alcoholism, and obesity, rather than to metho- trexate ...been liver biopsy, but this is associated with ... See full document
20
Cirrhotic cardiomyopathy among patients with liver cirrhosis
... Current management recommendations of CCM in- clude nonspecific supportive measures, pharmacological therapy and liver transplantation. Patients my benefit from salt restriction (to prevent water and sodium reten- ... See full document
70
25-Hydroxy Vitamin D: Novel Biomarker for the Diagnosis of Hepatocellular Carcinoma
... with chronic HCV ...with liver disease, 51 with cirrhosis and 49 without cirrhosis, including 38 patients with chronic hepatitis ... See full document
254
Integrative medicine and human health - the role of pre-, pro- and synbiotics
... Consumption of medical fibres should always be regarded as a surrogate for not consuming enough of fresh fruits and vegetables. Generally processed fibers are much less efficient in the body compared to natural fibres. ... See full document
71
<p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>
... this bivalency through rigid chromatin structure, whereas the maintenance of active chromatin states favors tumorigenesis, stem cell renewal, and proliferation. Some reviews describe the importance of epigenetic modi fi ... See full document
7
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
... lung disease, in particular to emphysema (Figure ...their liver or in monocytes, defined as individuals with the very rare homozygous Null variant, develop emphy- sema at younger age than subjects with the ... See full document
35
Alpha -1-antitrypsin deficiency, associated diseases and treatments: a review
... Normal M Alleles (phenotype MM) 90% of USA population have normal lung functions. Deficient alleles Z observed 2-3% of the USA population plasma level less than 35% of normal. Null no detect AT least common and most ... See full document
56
Title: ANTIDIABETIC AND ANTIOXIDANT ACTIVITY OF AQUEOUS ROOT EXTRACT OF CHLOROPHYTUM BORIVILIUANUM (SAFED MUSLI) Author: Hemlata Rathore, Bhushan Hatwar & Shishupal Bodhankar Keyword: Chlorophytum boriviliuanum, Antidiabetic & AntioxidantPage No: 37-43DOI: 10.30876/JOHR.8.3.2019.37-43Abstract: Objective: To investigate the antidiabetic effect of aqueous extract of Chlorophytum borivilianum (safed musli) root. Methods: The collected roots were washed; shade dried and was pulverized with a me chanical pulverizer for the size reduction. It was then passed through mesh of size # 60 and the fine powder was collected and was used for the experiment for powder microscopy and preparation of extract. The root powder (1000 g) was subjected to cold maceration in 2 L of sterile distilled water for 48 hours at room temperature, filtered into a clean round bottom flask. The a- Glucosidase inhibitory activity was conducted where 100µl of a sample of different concentrations was incubated with 50µl a-glucosidase (1.0 U/ml) (from Saccharomyces cerevisiae) in phosphate buffer (0.1 M, pH 6.8) for 10 min at 37°C. The reaction was initiated by addition of 50 µl of substrate: 5 mM, p-nitrophenyl-a-D glucopyranoside in a 0.1 M phosphate buffer at pH 6.8. P-nitrophenol’s release kinetics. The a -Amylase Inhibition where 250µL of the extract (5mg/mL) was preincubated with 250µL of -amylase solution for 10min at 25°C in one set of tubes. In another set of tubes -amylase was preincubated with 250µL of phosphate buffer (pH 6.9). 250µL of starch solution at increasing concentrations (0.30–5.0mg/mL) was added to both sets of reaction mixtures to start the reaction. The mixture was then incubated for 10min at 25°C and then boiled for 5min after the addition of 500µL of DNS to stop the reaction. Results: In this study acarbose was also used as a standard drug for a-glucosidase inhibitor. Acarbose at a concentration of (100-1000 µg/ml) showed a-glucosidase inhibitory activity from 30. 31±0.1084to 84.05±0.2075% with an IC value 411.436567µg dry extract, & acarbose was also used as a standard drug for a amylase inhibitor. Acarbose at a concentration of (100-1000 µg/ml) showed a-glucosidase inhibitory activity from 23.33±0.1415 to 62.05±0.2725% with an IC value 236.774194µg dry extract. Conclusions: As a result, we found that the extract of C. boriviliamum have free radical scavenging activity and inhibitory activity against a-amylase and a-glucosidase and this therapeutic potentiality could be exploited in the management of post prandial hyperglycemia in the treatment of type 2 diabetes mellitus. Download PDF
... damages the body through its promotion of oxidation, increasing the level of free radicals in the body. Harmful levels of iron can be accumulated in body simply by eating too of the wrong foods and supplements. The human ... See full document
11
Remembering the forgotten non-communicable diseases
... Kidney Disease Prognosis Consortium) has established a rich resource, comprising over one million people with CKD in various stages ...cardiovascular disease, hospitalizations, infections, mortality and ... See full document
28
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
... for liver cirrhosis, including chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, alcohol-related liver disease (ARLD), and obesity- related non-alcoholic fatty ... See full document
18
Retroperitoneal fibrosis: retrospective descriptive study on clinical features and management
... Clinical data of 17 patients with RPF between 1998 and 2013 were collected and analyzed. Nine patients were males and eight patients were females. The mean age was 62 ± 18 years (ranged 29–83 years). Eleven patients had ... See full document
12
Variations in codons 84 101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection
... with chronic liver ...with chronic liver ...20 chronic liver disease ...advanced liver diseases (chronic active hepatitis and cirrhosis), whereas only ... See full document
8
Clinical profile, prognostic factors and outcomes in anti tuberculous drug induced liver injury.
... Isoniazid was first used in 1950s.It carries 20% risk of biochemical hepatitis although overt hepatitis is much lower [56]. Although both metabolic and immunologic factors are likely to be involved in DILI, ... See full document
6
Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6
... with chronic liver disease (chronic hepatitis, liver cirrhosis, and hep- atocellular carcinoma), with the prevalences being 28% (13 of 46), 22% (10 of 46), and 15% (7 of 46), ... See full document
107
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
... one disease stage to ...NAFLD disease progression, transitions to other disease states were assumed to be unobserved (as is often the case in clinical practice), with the exception of transitions to ... See full document
10
Related subjects